132 related articles for article (PubMed ID: 11012109)
1. Prognostic factors in dogs with urinary bladder carcinoma.
Rocha TA; Mauldin GN; Patnaik AK; Bergman PJ
J Vet Intern Med; 2000; 14(5):486-90. PubMed ID: 11012109
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
[TBL] [Abstract][Full Text] [Related]
3. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder.
Chun R; Knapp DW; Widmer WR; DeNicola DB; Glickman NW; Kuczek T; Degortari A; Han CM
J Vet Intern Med; 1997; 11(5):279-83. PubMed ID: 9348494
[TBL] [Abstract][Full Text] [Related]
4. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study.
Poirier VJ; Forrest LJ; Adams WM; Vail DM
J Am Anim Hosp Assoc; 2004; 40(2):131-6. PubMed ID: 15007049
[TBL] [Abstract][Full Text] [Related]
5. Neoplasms of the canine urinary bladder.
Strafuss AC; Dean MJ
J Am Vet Med Assoc; 1975 Jun; 166(12):1161-3. PubMed ID: 1141032
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
Upton ML; Tangner CH; Payton ME
J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous metastasis of transitional cell carcinoma in 12 dogs.
Reed LT; Knapp DW; Miller MA
Vet Pathol; 2013 Jul; 50(4):676-81. PubMed ID: 23136183
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs.
Moore AS; Cardona A; Shapiro W; Madewell BR
J Vet Intern Med; 1990; 4(3):148-52. PubMed ID: 2366224
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer.
Knapp DW; Glickman NW; Mohammed SI; DeNicola DB; Widmer WR; Bonney PL; DeGortari AE
Adv Exp Med Biol; 2002; 507():377-80. PubMed ID: 12664613
[No Abstract] [Full Text] [Related]
13. Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
Robat C; Burton J; Thamm D; Vail D
J Small Anim Pract; 2013 Feb; 54(2):67-74. PubMed ID: 23286739
[TBL] [Abstract][Full Text] [Related]
14. Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
Henry CJ; Flesner BK; Bechtel SA; Bryan JN; Tate DJ; Selting KA; Lattimer JC; Bryan ME; Grubb L; Hausheer F
J Vet Intern Med; 2018 Jan; 32(1):370-376. PubMed ID: 29080252
[TBL] [Abstract][Full Text] [Related]
15. Canine intranasal tumours treated with alternating carboplatin and doxorubin in conjunction with oral piroxicam: 29 cases.
Woodruff MJ; Heading KL; Bennett P
Vet Comp Oncol; 2019 Mar; 17(1):42-48. PubMed ID: 30146732
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for advanced transitional cell carcinoma of the urothelium: cisplatin or carboplatin?
Culine S
Eur Urol; 2007 Jul; 52(1):9-10. PubMed ID: 17239527
[No Abstract] [Full Text] [Related]
17. [Transitional cell carcinoma of the urinary bladder of a dog].
Odendaal JS; Bastianello SS
J S Afr Vet Assoc; 1982 Dec; 53(4):258-60. PubMed ID: 7182501
[TBL] [Abstract][Full Text] [Related]
18. Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases.
Gustafson TL; Biller B
J Am Anim Hosp Assoc; 2019; 55(5):243-248. PubMed ID: 31433219
[No Abstract] [Full Text] [Related]
19. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.
McMillan SK; Boria P; Moore GE; Widmer WR; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2011 Oct; 239(8):1084-9. PubMed ID: 21985349
[TBL] [Abstract][Full Text] [Related]
20. Tumours of the urinary bladder.
Pamukcu AM
Bull World Health Organ; 1974; 50(1-2):43-52. PubMed ID: 4371741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
